WASHINGTON (Reuters) – The minimally invasive aortic heart valve replacement system from Edwards Lifesciences Corp performed better than a rival product sold by Medtronic Inc in the first head-to-head study of the two, according to data from a small German trial presented at a…
Edwards heart valve system tops Medtronic version in small study
No comments:
Post a Comment